Explore the UK assisted dying debate, including the Terminally Ill Adults Bill, parliamentary progress, and landmark court cases shaping end-of-life law.
UK & Italian researchers launch ARCADIA consortium with £3m funding to define true remission and help children and adults with inflammatory arthritis live drug‑free.
For the first time, UCL researchers have used AI to identify two biologically distinct forms of multiple sclerosis, supporting the potential for more personalised care and improved treatment decisions for patients worldwide.
University of Sheffield researchers helped secure FDA approval for a new bone imaging method that could speed up osteoporosis drug trials, meaning new treatments may reach patients faster than ever.
New research from UCL reveals alarming levels of tooth decay in adults in England, highlighting the need for improved dental care and public health initiatives.
Researchers at King’s College London have developed an AI model that can detect strokes, brain tumours, and aneurysms from MRI scans, helping doctors make faster, more accurate diagnoses.
As winter illnesses surge across the UK, a new national initiative aims to help people with long-term respiratory conditions stay healthier and avoid unnecessary hospital visits.
A shock survey by charity Asthma + Lung UK reveals that more than 90% of people with COPD are receiving inadequate care, with those living in more deprived communities five times more likely to die from the condition.
A significant study from the University of Cambridge finds that everyday pesticides and industrial chemicals can kill beneficial gut bacteria, potentially harming digestion, immunity, and overall health.
A new AI tool rolled out across 70+ hospitals in England is helping doctors spot deadly clots faster, doubling thrombectomy rates and giving thousands of stroke patients a better shot at recovery.
The UK launches its first National Centre for Neurotechnology and Neurorestoration in Newcastle to advance cutting-edge treatments and clinical trials for people living with neurological conditions.
The University of Nottingham unveils the world's first mobile quantum brain scanner, designed to monitor the impact of blast exposure on the brain in real time.
Superintendent Pharmacist James O’Loan outlines the everyday challenges faced by individuals living with diabetes and how improvements in digital health are helping to improve management and care.
A UK inquiry finds that around 23,000 deaths in England could have been prevented if the national lockdown had begun a week earlier in March 2020, highlighting major government failings during the pandemic.
Contributors from the PKU community, including patient reps, key opinion leaders, and medical experts, discuss the implications of redefining ‘unmet medical need’ in the EU’s pharmaceutical legislation, emphasising the potential negative impact on patients, particularly those with rare diseases like phenylketonuria.
